ANIP — ANI Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.92bn
- $2.21bn
- $883.37m
Brief: ANI Pharmaceuticals Launches Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution
Brief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
Alimera Sciences down on filing lawsuit against ANI Pharma to close deal
Brief: ANI Pharmaceuticals Closes $316.25 Mln Convertible Senior Notes Offering
Brief: ANI Pharmaceuticals Prices Upsized $275.0 Million Convertible Senior Notes Offering
Brief: Ani Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
ANI Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: ANI Pharmaceuticals Q2 Adjusted EPS USD 1.02 Vs. IBES Estimate USD 0.95
ANI Pharmaceuticals Inc expected to post earnings of 95 cents a share - Earnings Preview
Brief: ANI Pharmaceuticals Announces FDA Approval And Launch Of Naproxen Delayed-Release Tablets, USP
Brief: ANI Pharmaceuticals Announces The FDA Approval And Launch Of Naproxen Delayed-Release Tablets, USP
Alimera Sciences soars nearly 80% on ANI Pharma buyout
Brief: Ani Pharmaceuticals Expands Rare Disease Business Through Acquisition Of Alimera Sciences
Brief: Ani Pharmaceuticals Announces The Launch Of Kionex® Suspension
ANI Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 1.21 Vs. IBES Estimate USD 1
ANI Pharmaceuticals Inc expected to post earnings of $1.00 a share - Earnings Preview
ANI Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary